Ocular Therapeutix, Inc. OCUL
$7.29
-4.95%
at last close
Market Cap$1.68 billion
P/E Ratio—
Div Yield—
Volume4.51M
52-Week Range
$6.23$16.44
Analyst Ratings
- Consensus
- Buy — 8 Buy · 0 Hold · 0 Sell (8 analysts)
- Avg. Price Target
- $25.63 (+251.5% upside)
Key Stats
- Today's Range
- $7.26 – $7.71
- 50-Day Range
- $7.18 – $11.74
- 52-Week Range
- $6.23 – $16.44
- Volume
- 4.51 million shs
- Average Volume
- 2.92 million shs
- Market Cap
- $1.68 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 1.47%
- Days to Cover
- 8.51
About Ocular Therapeutix, Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Related Stocks
Compare head-to-head: OCUL vs LLY·OCUL vs JNJ·OCUL vs ABBV·OCUL vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.